Zimmer has a 25 percent market share and has become a prime candidate for a buyout, according to AOL's DailyFinance.
Zimmer has a "very strong business franchise in orthopedics, which is experiencing very favorable long-term demographic trends with the aging baby boomer population worldwide," David A. Katz, chief investment officer of Matrix Asset Advisors, told the news source.
Katz pointed out that the average age of implant patients is 67 and that the first baby boomers are rapidly approaching that age.
Zimmer is an attractive stock that may be purchased by a larger company, says Katz.
It is an "attractive takeover candidate for a large health care company (domestic or foreign) that may want to diversify its revenue base at a time when major pharmaceutical companies face patent expirations," he told the news source.